0.10Open0.10Pre Close0 Volume180 Open Interest5.00Strike Price0.00Turnover471.23%IV321.49%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier18DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.2107Delta0.2249Gamma12.10Leverage Ratio-0.0100Theta0.0001Rho2.55Eff Leverage0.0008Vega
NRX Pharmaceuticals Stock Discussion
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic | NRXP Stock News
11 MINUTES AGO, 7:00 AM EDT
VIA PR NEWSWIRE
• Stability milestone supports submission of FDA New Drug Application by NRx for the use of intravenous ketamine to treat Suicidal Depression
• Ketamine is currently used off-label for this indication. However, FDA approval is typically required for patient...
HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion
HOPE Therapeutics, Inc., a subsidiary of
https://www.moomoo.com/t/news/post/42897644/mbyzFRmrUf
Benzinga· 1 min ago
No comment yet